Neogenomics (NEO) Non Operating Income (2010 - 2026)
Neogenomics (NEO) posted Non Operating Income of -$12000.0 for Q1 2026, down 114.29% quarter-over-quarter from $84000.0 in Q4 2025, and down 118.46% year-on-year from $65000.0 in Q1 2025.
Neogenomics (NEO) Non Operating Income (2010 - 2026) Analysis & Trends
Neogenomics (NEO) has reported Non Operating Income for 15 consecutive years, with -$12000.0 the latest figure, recorded in Q1 2026.
- Non Operating Income for Q1 2026 came in at -$12000.0, down 118.46% year-over-year; the trailing twelve-month figure through Mar 2026 was $219000.0 (up 529.41% YoY), and the FY2025 annual result was $296000.0, up 178.1% from the prior year.
- Non Operating Income was -$12000.0 for Q1 2026 at Neogenomics, down from $84000.0 in the prior quarter.
- Over five years, Non Operating Income peaked at $730000.0 in Q2 2023 and troughed at -$431000.0 in Q4 2024.
- Average Non Operating Income over 5 years is $19764.7, with a median of -$1000.0 recorded in 2022.
- Year-over-year, Non Operating Income plunged 484.0% in 2023 and surged 24200.0% in 2025.
- Over 5 years, Non Operating Income stood at -$1000.0 in 2022, then soared by 12500.0% to $124000.0 in 2023, then tumbled by 447.58% to -$431000.0 in 2024, then surged by 119.49% to $84000.0 in 2025, then sank by 114.29% to -$12000.0 in 2026.
- Per Business Quant data, the three most recent Non Operating Income figures were -$12000.0 in Q1 2026, $84000.0 in Q4 2025, and -$335000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 1.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | -9.00 Mn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | -73.00 Mn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | - |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 9.60 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 21.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | -4.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | -52.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 7.33 Mn |
| 10 | Neogenomics | 1.93 Bn | 1.79 Bn | 80.86 Mn | -12,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12,000.00 |
| Dec 31, 2025 | 84,000.00 |
| Sep 30, 2025 | -335,000.00 |
| Jun 30, 2025 | 482,000.00 |
| Mar 31, 2025 | 65,000.00 |
| Dec 31, 2024 | -431,000.00 |
| Sep 30, 2024 | 317,000.00 |
| Jun 30, 2024 | -2,000.00 |
| Mar 31, 2024 | -263,000.00 |
| Dec 31, 2023 | 124,000.00 |
| Sep 30, 2023 | -96,000.00 |
| Jun 30, 2023 | 730,000.00 |
| Mar 31, 2023 | -114,000.00 |
| Dec 31, 2022 | -1,000.00 |
| Sep 30, 2022 | 25,000.00 |
| Jun 30, 2022 | -405,000.00 |
| Mar 31, 2022 | 168,000.00 |
| Dec 31, 2021 | -930,000.00 |
| Sep 30, 2021 | 89,000.00 |
| Jun 30, 2021 | 171,000.00 |